542 related articles for article (PubMed ID: 36807081)
1. Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research.
Khan MA; Haider N; Singh T; Bandopadhyay R; Ghoneim MM; Alshehri S; Taha M; Ahmad J; Mishra A
Metab Brain Dis; 2023 Mar; 38(3):873-919. PubMed ID: 36807081
[TBL] [Abstract][Full Text] [Related]
2. Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson's Disease.
Wang Y; Yang Z; Le W
Neurosci Bull; 2017 Oct; 33(5):543-551. PubMed ID: 28762215
[TBL] [Abstract][Full Text] [Related]
3. Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?
Le W; Dong J; Li S; Korczyn AD
Neurosci Bull; 2017 Oct; 33(5):535-542. PubMed ID: 28866850
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in Parkinson's disease (recent update).
Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
[TBL] [Abstract][Full Text] [Related]
5. microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.
Leggio L; Vivarelli S; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Marchetti B; Iraci N
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236052
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging over the course of Parkinson's disease: from early detection of the at-risk patient to improving pharmacotherapy of later-stage disease.
Seibyl J; Russell D; Jennings D; Marek K
Semin Nucl Med; 2012 Nov; 42(6):406-14. PubMed ID: 23026362
[TBL] [Abstract][Full Text] [Related]
7. Candidate biomarkers for Parkinson's disease.
Khodadadian A; Hemmati-Dinarvand M; Kalantary-Charvadeh A; Ghobadi A; Mazaheri M
Biomed Pharmacother; 2018 Aug; 104():699-704. PubMed ID: 29803930
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson's Disease.
Tryphena KP; Anuradha U; Kumar R; Rajan S; Srivastava S; Singh SB; Khatri DK
J Alzheimers Dis; 2023; 94(s1):S187-S202. PubMed ID: 35848027
[TBL] [Abstract][Full Text] [Related]
9. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.
Sarkar S; Raymick J; Imam S
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353
[TBL] [Abstract][Full Text] [Related]
11. Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.
Farotti L; Paciotti S; Tasegian A; Eusebi P; Parnetti L
Expert Rev Mol Diagn; 2017 Aug; 17(8):771-780. PubMed ID: 28604235
[TBL] [Abstract][Full Text] [Related]
12. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson's disease.
Lu J; Xu Y; Quan Z; Chen Z; Sun Z; Qing H
Neuroscience; 2017 Dec; 365():70-82. PubMed ID: 28964753
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in Parkinson's disease: Advances and strategies.
Delenclos M; Jones DR; McLean PJ; Uitti RJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946
[TBL] [Abstract][Full Text] [Related]
15. Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson's disease.
Giri B; Seamon M; Banerjee A; Chauhan S; Purohit S; Morgan J; Baban B; Wakade C
Metab Brain Dis; 2022 Aug; 37(6):1687-1696. PubMed ID: 33881722
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for the diagnosis and management of Parkinson's disease.
Waragai M; Sekiyama K; Fujita M; Tokuda T; Hashimoto M
Expert Opin Med Diagn; 2013 Jan; 7(1):71-83. PubMed ID: 23530844
[TBL] [Abstract][Full Text] [Related]
17. The Potential Roles of Extracellular Vesicles as Biomarkers for Parkinson's Disease: A Systematic Review.
Valencia J; Ferreira M; Merino-Torres JF; Marcilla A; Soriano JM
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232833
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Biomarkers for Parkinson's Disease.
He R; Yan X; Guo J; Xu Q; Tang B; Sun Q
Front Aging Neurosci; 2018; 10():305. PubMed ID: 30364199
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for Parkinson's Disease: How Good Are They?
Li T; Le W
Neurosci Bull; 2020 Feb; 36(2):183-194. PubMed ID: 31646434
[TBL] [Abstract][Full Text] [Related]
20. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
Meles SK; Oertel WH; Leenders KL
Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
